LINK-A:揭示了它在人类瘤中的功能作用和临床意义
Bing Liao1, Jialing Wang2, Yilin Xie3
1Department of Otorhinolaryngology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Frontiers in cell and developmental biology
|April 22, 2024
概括
长非编码RNA LINK-A (LINC01139) 是各种癌症中的关键瘤基因. 本综述详细介绍了其在癌症进展,诊断和治疗耐药性方面的作用,强调了其作为点的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 长非编码RNAs (lncRNAs) 在癌症的发展和进展中起着重要的作用.
- LINK-A (LINC01139) 是一种致癌性 lncRNA,在各种固体和液体瘤中经常升高调节.
- 它的失调与关键的癌症特征和信号通路有关.
研究的目的:
- 提供对LINK-A在癌症中的分子机制和临床意义的全面审查.
- 探索LINK-A作为癌症诊断和预后的潜在生物标志物的作用.
- 讨论LINK-A参与治疗耐药性及其作为治疗点的潜力.
主要方法:
- 关于癌症LINK-A现有研究的文献综述.
- 对LINK-A参与与癌症相关的信号通路 (例如AKT,HIF1α) 的分析.
- 检查LINK-A与瘤活动 (扩散,亡,EMT,入侵,迁移,糖解) 的关联.
主要成果:
- 在多种癌症类型中,包括乳腺癌,卵巢癌,肺癌和血液恶性瘤中,LINK-A的升级调节.
- 它调节关键的致癌途径和过程,有助于瘤的进展.
- LINK-A表达与临床特征相关,表明其作为生物标记物的实用性.
- LINK-A与AKT抑制剂和免疫疗法等疗法的耐药性有关.
结论:
- LINK-A 是一种重要的致癌性 lncRNA,在癌症中具有多方面的作用.
- 它作为各种癌症的诊断和预后生物标志物具有前途.
- 向LINK-A是一个潜在的治疗策略,可以克服治疗耐药性并改善癌症的结果.
相关概念视频
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Cytoskeletal Linker Proteins - Plakins
2.3K
Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...
2.3K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K


